TE_167
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSp |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | ATP13A2 |
| Class | Chimeric |
| Coding | Non-coding, Other |
| Tumor-specific score | 0.97 |
| Counts of samples | TCGA_tumor:435; TCGA_normal:21; GTEx:484 |
| TSS | chr1(-):16999374 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_167.1 | ATP13A2 | Chimeric | Other | MKFVAALSVLALLGTIYSIFILYRNRVPLNEIVIRALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIHPLRINLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQAFLPLVPEPRRLPVGPLLRALATCHALSRLQDTPVGDPMDLKMVESTGWVLEEEPAADSAFGTQVLAVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSALQRMSVVVAWPGATQPEAYVKGSPELVAGLCNPETVPTDFAQMLQSYTAAGYRVVALASKPLPTVPSLEAAQQLTRDTVEGDLSLLGLLVMRNLLKPQTTPVIQALRRTRIRAVMVTGDNLQTAVTVARGCGMVAPQEHLIIVHATHPERGQPASLEFLPMESPTAVNGVKVLVQGTVFARMAPEQKTELVCELQKLQYCVGMCGDGANDCGALKAADVGISLSQAEASVVSPFTSSMASIECVPMVIREGRCSLDTSFSVFKYMALYSLTQFISVLILYTINTNLGDLQFLAIDLVITTTVAVLMSRTGPALVLGRVRPPGALLSVPVLSSLLLQMVLVTGVQLGGYFLTLAQPWFVPLNRTVAAPDNLPNYENTVVFSLSSFQYLILAAAVSKGAPFRRPLYTNERARPVP | chr1(-):16986338,16986358,16986805,16986956,16987046,16987269,16988138,16988234,16988322,16988474,16989691,16989770,16990127,16990287,16991734,16991858,16992009,16992129,16992243,16992402,16992486,16992581,16993629,16993835,16995976,16996164,16996254,16996300,16996386,16996496,16997020,16997175,16999255,16999375 |
| teRNA_167.2 | ATP13A2 | Chimeric | Other | MKFVAALSVLALLGTIYSIFILYRNRVPLNEIVIRALDLVTVVVPPALPAAMTVCTLYAQSRLRRQGIFCIHPLRINLGGKLQLVCFDKTGTLTEDGLDVMGVVPLKGQAFLPLVPEPRRLPVGPLLRALATCHALSRLQDTPVGDPMDLKMVESTGWVLEEEPAADSAFGTQVLAVMRPPLWEPQLQAMEEPPVPVSVLHRFPFSSALQRMSVVVAWPGATQPEAYVKGSPELVAGLCNPETVPTDFAQMLQSYTAAGYRVVALASKPLPTVPSLEAAQQLTRDTVEGDLSLLGLLVMRNLLKPQTTPVIQALRRTRIRAVMVTGDNLQTAVTVARGCGMVAPQEHLIIVHATHPERGQPASLEFLPMESPTAVNGVKDPDQAASYTVEPDPRSRHLALSGPTFGIIVKHFPKLLPKVLVQGTVFARMAPEQKTELVCELQKLQYCVGMCGDGANDCGALKAADVGISLSQAEASVVSPFTSSMASIECVPMVIREGRCSLDTSFSVFKYMALYSLTQFISVLILYTINTNLGDLQFLAIDLVITTTVAVLMSRTGPALVLGRVRPPGALLSVPVLSSLLLQMVLVTGVQLGGYFLTLAQPWFVPLNRTVAAPDNLPNYENTVVFSLSSFQYLILAAAVSKGAPFRRPLYTNVPFLVALALLSSVLVGLVLVPGLLQGPLALRNITDTGFKLLLLGLVTLNFVGAFMLESVLDQCL | chr1(-):16986338,16986358,16986463,16986632,16986805,16986956,16987046,16987269,16988138,16988234,16988322,16988474,16989691,16989770,16989887,16990003,16990127,16990287,16991734,16991858,16992009,16992129,16992243,16992402,16992486,16992581,16993629,16993835,16995976,16996164,16996254,16996300,16996386,16996496,16997020,16997175,16999255,16999375 |
| teRNA_167.3 | ATP13A2 | Chimeric | Non-coding | Non-coding | chr1(-):16996144,16996164,16996254,16996300,16996386,16996496,16997020,16997175,16999255,16999375 |
| teRNA_167.4 | ATP13A2 | Chimeric | Non-coding | Non-coding | chr1(-):16996144,16996164,16996254,16996300,16997020,16997175,16999255,16999375 |
| teRNA_167.5 | ATP13A2 | Chimeric | Non-coding | Non-coding | chr1(-):16996144,16996164,16996254,16996300,16996386,16996478,16997020,16997175,16999255,16999375 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
